Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance

被引：0
|
作者：
Zatreanu, Diana A.
Robinson, Helen M. R.
Alkhatib, Omar
Boursier, Marie
Finch, Harry
Geo, Lerin
Grande, Diego
Grinkevich, Vera
Heald, Robert
Langdon, Sophie
Majithiya, Jayesh
McWhirter, Claire
Martin, Niall M. B.
Moore, Shaun
Neves, Joana
Rajendra, Eeson
Ranzani, Marco
Schaedler, Theresia
Stockley, Martin
Wiggins, Kimberley
Brough, Rachel
Sridhar, Sandhya
Gulati, Aditi
Shao, Nan
Badder, Luned M.
Novo, Daniela
Knight, Eleanor G.
Marlow, Rebecca
Haider, Syed
Callen, Elsa
Hewitt, Graeme
Schimmel, Joost
Prevo, Remko
Alli, Christina
Ferdinand, Amanda
Bell, Cameron
Blencowe, Peter
Calder, Mathew
Charles, Mark
Curry, Jayne
Ekwuru, Tennyson
Ewings, Katherine
Nussenzweig, Andre
Tijsterman, Marcel
Tutt, Andrew
Boulton, Simon J.
Higgins, Geoff S.
Pettitt, Steve
Smith, Graeme C. M.
Lord, Christopher J.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-P056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P056
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
    Diana Zatreanu
    Helen M. R. Robinson
    Omar Alkhatib
    Marie Boursier
    Harry Finch
    Lerin Geo
    Diego Grande
    Vera Grinkevich
    Robert A. Heald
    Sophie Langdon
    Jayesh Majithiya
    Claire McWhirter
    Niall M. B. Martin
    Shaun Moore
    Joana Neves
    Eeson Rajendra
    Marco Ranzani
    Theresia Schaedler
    Martin Stockley
    Kimberley Wiggins
    Rachel Brough
    Sandhya Sridhar
    Aditi Gulati
    Nan Shao
    Luned M. Badder
    Daniela Novo
    Eleanor G. Knight
    Rebecca Marlow
    Syed Haider
    Elsa Callen
    Graeme Hewitt
    Joost Schimmel
    Remko Prevo
    Christina Alli
    Amanda Ferdinand
    Cameron Bell
    Peter Blencowe
    Chris Bot
    Mathew Calder
    Mark Charles
    Jayne Curry
    Tennyson Ekwuru
    Katherine Ewings
    Wojciech Krajewski
    Ellen MacDonald
    Hollie McCarron
    Leon Pang
    Chris Pedder
    Laurent Rigoreau
    Martin Swarbrick
    Nature Communications, 12
  • [2] Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
    Zatreanu, Diana
    Robinson, Helen M. R.
    Alkhatib, Omar
    Boursier, Marie
    Finch, Harry
    Geo, Lerin
    Grande, Diego
    Grinkevich, Vera
    Heald, Robert A.
    Langdon, Sophie
    Majithiya, Jayesh
    McWhirter, Claire
    Martin, Niall M. B.
    Moore, Shaun
    Neves, Joana
    Rajendra, Eeson
    Ranzani, Marco
    Schaedler, Theresia
    Stockley, Martin
    Wiggins, Kimberley
    Brough, Rachel
    Sridhar, Sandhya
    Gulati, Aditi
    Shao, Nan
    Badder, Luned M.
    Novo, Daniela
    Knight, Eleanor G.
    Marlow, Rebecca
    Haider, Syed
    Callen, Elsa
    Hewitt, Graeme
    Schimmel, Joost
    Prevo, Remko
    Alli, Christina
    Ferdinand, Amanda
    Bell, Cameron
    Blencowe, Peter
    Bot, Chris
    Calder, Mathew
    Charles, Mark
    Curry, Jayne
    Ekwuru, Tennyson
    Ewings, Katherine
    Krajewski, Wojciech
    MacDonald, Ellen
    McCarron, Hollie
    Pang, Leon
    Pedder, Chris
    Rigoreau, Laurent
    Swarbrick, Martin
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] Targeting PARP inhibitor resistance with Polθ inhibitors
    Zatreanu, Diana
    Robinson, Helen
    Alkhatib, Omar
    Boursier, Marie
    Finch, Harry
    Geo, Lerin
    Grande, Diego
    Grinkevich, Vera
    Heald, Robert
    Langdon, Sophie
    Majithiya, Jayesh
    McWhirter, Claire
    Martin, Niall
    Moore, Shaun
    Neves, Joana
    Rajendra, Eeson
    Ranzani, Marco
    Schaedler, Theresia
    Stockley, Martin
    Wiggins, Kimberley
    Brough, Rachel
    Sridhar, Sandhya
    Gulati, Aditi
    Shao, Nan
    Badder, Luted
    Novo, Daniela
    Knight, Eleanor
    Marlow, Rebecca
    Haider, Syed
    Callen, Elsa
    Hewitt, Graeme
    Schimmel, Joost
    Prevo, Remko
    Alli, Christina
    Ferdinand, Amanda
    Bell, Cameron
    Blencowe, Peter
    Bot, Chris
    Calder, Mathew
    Charles, Mark
    Curry, Jayne
    Ekwuru, Tennyson
    Nussenzweig, Andre
    Tijsterman, Marcel
    Tutt, Andrew N.
    Boulton, Simon
    Higgins, Geoff
    Pettitt, Stephen J.
    Smith, Graeme C.
    Lord, Christopher J.
    CANCER RESEARCH, 2022, 82 (12)
  • [4] Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
    Cong, Ke
    Peng, Min
    Kousholt, Arne Nedergaard
    Lee, Wei Ting C.
    Lee, Silviana
    Nayak, Sumeet
    Krais, John
    VanderVere-Carozza, Pamela S.
    Pawelczak, Katherine S.
    Calvo, Jennifer
    Panzarino, Nicholas J.
    Turchi, John J.
    Johnson, Neil
    Jonkers, Jos
    Rothenberg, Eli
    Cantor, Sharon B.
    MOLECULAR CELL, 2021, 81 (15) : 3128 - +
  • [5] PARP inhibitors: Synthetic lethality in the clinic
    Lord, Christopher J.
    Ashworth, Alan
    SCIENCE, 2017, 355 (6330) : 1152 - 1158
  • [6] Synthetic lethality of PARP inhibitors and metformin in BRCA1 intact ovarian cancer
    Hijaz, M.
    Chhina, J.
    Dar, S.
    Tebbe, C.
    Al-Wahab, Z.
    Hanna, R. K.
    Rattan, R.
    Munkarah, A. R.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 18 - 18
  • [7] Inducing Synthetic Lethality using PARP Inhibitors
    Boss, David S.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03): : 192 - 195
  • [8] Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
    Oei, Arlene L.
    van Leeuwen, Caspar M.
    Ahire, Vidhula R.
    Rodermond, Hans M.
    ten Cate, Rosemarie
    Westermann, Anneke M.
    Stalpers, Lukas J. A.
    Crezee, Johannes
    Kok, H. Petra
    Krawczyk, Przemek M.
    Kanaar, Roland
    Franken, Nicolaas A. P.
    ONCOTARGET, 2017, 8 (17) : 28116 - 28124
  • [9] Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality
    Le, Bac Viet
    Podszywalow-Bartnicka, Paulina
    Piwocka, Katarzyna
    Skorski, Tomasz
    CANCERS, 2022, 14 (23)
  • [10] The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
    Helleday, Thomas
    MOLECULAR ONCOLOGY, 2011, 5 (04): : 387 - 393
12345